Literature DB >> 8124766

Marchantin A trimethyl ether: its molecular structure and tubocurarine-like skeletal muscle relaxation activity.

Z Taira1, M Takei, K Endo, T Hashimoto, Y Sakiya, Y Asakawa.   

Abstract

Marchantin A is a novel macrocyclic bis(bibenzyl)ether isolated from the liverwort Marchantia species. An X-ray study of its derivative, marchantin A trimethyl ether, revealed that the molecule possesses convex and concave surfaces, with a central hole on the concave surface. The centroid-centroid separations of opposing benzene rings are 8.80 and 4.55 A. A pharmacological study showed that the skeletal muscle relaxation activity is about 3.5 times less potent than that of d-tubocurarine. A comparison of the X-ray structure of marchantin A trimethyl ether and that of O,O',N-trimethyltubocurarine reported by Sobell et al. revealed that the molecules share almost the same macrocyclic bis(bibenzyl)ether skeleton structure, portions of which may therefore be crucial for the skeletal muscle relaxation activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8124766     DOI: 10.1248/cpb.42.52

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

1.  In vitro antitrypanosomal activity of bis(bibenzyls)s and bibenzyls from liverworts against Trypanosoma brucei.

Authors:  Kazuhiko Otoguro; Aki Ishiyama; Masato Iwatsuki; Miyuki Namatame; Aki Nishihara-Tukashima; Hiroaki Kiyohara; Toshihiro Hashimoto; Yoshinori Asakawa; Satoshi Omura; Haruki Yamada
Journal:  J Nat Med       Date:  2011-09-16       Impact factor: 2.343

2.  Anti-influenza activity of marchantins, macrocyclic bisbibenzyls contained in liverworts.

Authors:  Yuma Iwai; Kouki Murakami; Yasuyuki Gomi; Toshihiro Hashimoto; Yoshinori Asakawa; Yoshinobu Okuno; Toyokazu Ishikawa; Dai Hatakeyama; Noriko Echigo; Takashi Kuzuhara
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

Review 3.  Bibenzyls and bisbybenzyls of bryophytic origin as promising source of novel therapeutics: pharmacology, synthesis and structure-activity.

Authors:  Samapika Nandy; Abhijit Dey
Journal:  Daru       Date:  2020-08-15       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.